Follow-on RifAximin for the Prevention of recurrence following standard treatment of Infection with Clostridium Difficile (RAPID): a randomised placebo controlled trial

July 2019

Author(s): Major G, Bradshaw L, Boota N, Sprange K, Diggle M, Montgomery A, et al

Details: Gut. 2019;68(7):1224-31

NIHR Acknowledged: Yes

Photo Name Bio
dr-giles-major1 Dr Giles Major